Feedback / Questions
CBX-663 - Crossbow Therap
https://www.businesswire.com/news/home/20250723684640/en/Crossbow-Therapeutics-Nominates-its-Second-Development-Candidate-CBX-663-a-Broadly-Acting-Therapeutic-for-a-Wide-Range-of-Solid-and-Hematologic-Malignancies
Jul 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next